India faces severe heatwaves. Dangerous heat now affects large areas with little relief. This crisis demands action beyond meteorology. Hea...

There are sectors that have not quite followed the war script. Take the auto sector, for instance. A surge in oil prices is supposed to be ...

Telecom operators Reliance Jio, Airtel, and Vodafone Idea have rejected the Telecom Regulatory Authority of India's (Trai) proposal for man...

It has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's budget now includes funds for tourism development. This marks a shift in how the country views its mountains. Nepal has a well-orga...

The RBI’s decision to keep the repo rate unchanged at 5.25% has provided relief to home loan borrowers, but rising inflation could trigger ...

The latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...

Borrowers struggling with debt often face harassment from recovery agents through abusive calls, threats, public shaming, and unauthorised ...

Japan's Development Bank of Japan Inc. has entered India's residential property market. It committed capital to HDFC Capital's affordable a...

If the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...

President Trump's strong influence in Republican primaries presents a challenge for the party's upcoming midterm elections. Voters are repo...

Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

India's government struggles to close ailing state-owned companies. Bureaucratic hurdles and complex asset sales delay closures. This ties ...

Rising U.S. Treasury yields and surging oil prices are creating economic risks for the White House, impacting inflation and consumer borrow...

Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...

Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...